Axial Spondyloarthritis
Radiographic Sacroiliitis vs MRI Structural Lesions for Axial Spondyloarthritis Classification
April 16, 2018Researchers sought to investigate the utility of adding structural MRI lesions of the sacroiliac joints to the imaging criterion of the ASAS axSpA criteria.
Sustained Clinical, Functional Improvements With Adalimumab in Axial Spondyloarthritis
April 13, 2018Results from the ABILITY-1 study show sustained clinical and functional improvements with adalimumab treatment in nonradiographic axial spondyloarthritis.
Disease Activity in Axial Spondyloarthritis Generally Low, Stable During Pregnancy
April 05, 2018Researchers found that disease activity was highest during the second trimester of pregnancy.
Trabecular Bone Score May Predict Future Vertebral Fracture in Axial Spondyloarthritis
April 04, 2018Researchers found that trabecular bone scores may be predictive of future vertebral fractures in patients with axial spondyloarthritis.
Comorbid Fibromyalgia and Axial Spondyloarthritis: Response to TNF Blocker Therapy
March 22, 2018Researchers sought to confirm whether concomitant fibromyalgia has a negative effect on TNF blocker response.
Adalimumab Reduces Whole-Body MRI Indices of Inflammation in axSpA
March 21, 2018Adalimumab may decrease whole-body magnetic resonance imaging indices of inflammation in both axial and peripheral joints and enthuses in axSpA.
Anti-CD74 Antibodies Have Limited Diagnostic Value in Early Axial Spondyloarthritis
March 20, 2018Anti-CD74 IgG and IgA antibodies have limited value in the diagnosis of early axial spondyloarthritis in younger patients who present with early back pain.
Adherence to Anti-TNF Blocker Recommendations in axSpA Linked to Improved Quality of Life
March 16, 2018Adherence to recommendations for the initiation and continuation of TNF-alpha blocker therapy in patients with axial spondyloarthritis is associated with improved quality of life.
Challenges of Targeting Remission in Axial Spondyloarthritis
March 09, 2018Current guidelines define remission as the absence of clinical and laboratory evidence of significant inflammatory disease, but the tools that are currently available are inadequate to assess clinical remission.
Functional Status in Early Axial Spondyloarthritis: The Role of Spinal Structural Damage
February 08, 2018Results of the GESPIC study found that structural damage in the spine and disease activity were both determinants of functional status and spine mobility in patients with early axial spondyloarthritis.
Sustained Reduction in axSpA Joint Inflammation With Certolizumab Pegol
February 05, 2018Decreases in spinal and sacroiliac joint inflammation on MRI were maintained through 204 weeks with certolizumab pegol treatment.
Diagnostic Value of Repeat MRI in Suspected Early Axial Spondyloarthritis
December 21, 2017The diagnostic utility of repeat MRI was examined in people who were HLA-B27-negative or positive.
Axial Spondyloarthritis Classification: Assessing Need for Spine MRI
August 28, 2017Researchers recommended against including MRI in the Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis.
ASAS/EULAR Revise Axial Spondyloarthritis Management Recommendations
January 25, 2017Collaborative document provides guidance on non-pharmacological and pharmacological management in patients with axial spondyloarthritis.
Treatment Efficacy and Clinical Burden in Nonradiographic Axial Spondyloarthritis vs Ankylosing Spondylitis
January 06, 2017New research compared treatment efficacy by drug class and clinical and humanistic burdens of nr-axSpA with those of AS.
AxSpA Therapy Can Be Guided With Predictive Modeling
December 07, 2016Trajectory modeling of axial SpA is feasible and suggests up to a third of patents may be under-treated.
Reliability of MRI-Detected Structural Lesions for AxSpA Classification
September 11, 2016The utility of considering MRI-detected structural lesions in sacroiliac joints for the classification of patients being evaluated for axial spondyloarthritis was explored in a recent study.
Factors Predictive of Early SpA SI Joint Radiographic Progression
August 18, 2016Researchers sought to find the percentage of patients who will progress from nonradiographic axial SpA to radiographic axial SpA over time.
Aligning Clinical Care: Which Aspects of ASAS Do AxSpA Patients Find Most Concerning?
June 27, 2016Findings in this study can help clinicians tailor axial spondyloarthritis clinical care appropriateiy to better address patients' needs.
Calprotectin as a Reliable Surrogate Marker for Bowel Inflammation in SpA?
May 16, 2016Fecal levels of calprotectin have been used as biomarkers of inflammatory bowel disease activity, and researchers speculated that its levels may be viable markers for bowel involvement in spondyloarthritis as well.
Systematic Review of Feasible Anti-TNF Tapering Strategies in AxSpA
April 11, 2016Tapering of anti-TNF therapy can facilitate sustained remission or lower disease activity in most patients with axial spondyloarthritis while ameliorating both risk for adverse events and treatment costs.
Uveitis Flares In Axial Spondyloarthritis Controlled With Certolizumab Pegol
February 01, 2016Uveitis flares occurred at a lower rate in patients treated with certolizumab pegol vs placebo.
Rheumatology Advisor Articles
- EULAR Releases Recommendations for Managing Behcet Syndrome
- FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA
- Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis
- Precision Medicine in Rheumatology: Personalizing Treatment for Improved Clinical Outcomes
- Differences Identified in Serious Infection Risk Between Biologic Drugs for Rheumatoid Arthritis
- EULAR Releases Recommendations for Managing Behcet Syndrome
- USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention
- Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis
- Ultrasound Synovitis Detection Predicts Loss of Remission in Rheumatoid Arthritis
- Quality of SLE Care Assessed in Specialized Lupus vs General Rheumatology Clinic
- FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA
- Patients Prefer Physicians Who Engage in Face-to-Face Visits
- Comparing Burden of Psoriatic Arthritis With Different Definitions of Disease Activity
- Tibiofemoral MRI May Be Predictive of Radiographic Knee OA in Overweight, Obese Women
- Why is #MeToo Missing From Medical Schools?